NetraMark combines proprietary QML/ML algorithms with cross-domain expertise to bring ML commercialization into reality, starting with the pharmaceutical space in drug development where we utilize large and small data in order to help pharmaceutical companies understand their patient populations better. Our technology allows for the utilization of phase II data in order to optimize phase III trials from the vantage of their specific patient population. 

Clinical Trials

Health Data

Life Sciences

Pharmaceutical

NetraMark

NetraMark's headquarters in Toronto, Canada

George Achilleos

Waqar Qadir

Swapan Kakumanu

Luca Pani

Joseph Geraci

NetraMark

Org chart

Teams

Offices

Similar companies